Targeted Oncology presents Case-Based Peer Perspectives. In each video, expert physicians provide insight on managing oncology-based patient cases that highlight the use of novel agents in clinical practice.
Stage IV High-Risk Mantle Cell Lymphoma
Read More
Multiple Myeloma With Symptomatic Progression: Case 2
Multiple Myeloma With Symptomatic Progression
Multiple Myeloma With Symptomatic Progression: Case 1
<em>ALK</em>-Translocated Non-Small Cell Lung Cancer With Bone Metastases
ALK-Translocated Non-Small Cell Lung Cancer With Bone Metastases
Recurrent Metastatic Gastrointestinal Stromal Tumor
High-Risk Primary Myelofibrosis
Hydroxyurea Resistant Polycythemia Vera
Treatment of BRAF Mutated Non-Small Cell Lung Cancer
Treatment of ALK+ Non-Small Cell Lung Cancer
Unresectable Metastatic Gastrointestinal Stromal Tumor: Case 2
Unresectable Metastatic Gastrointestinal Stromal Tumor
Unresectable Metastatic Gastrointestinal Stromal Tumor: Case 1
Surgically Unresectable Metastatic Colorectal Cancer Case: 2
Surgically Unresectable Metastatic Colorectal Cancer
Surgically Unresectable Metastatic Colorectal Cancer Case: 1
Case Presentation in Advanced Colon Cancer Case: 2
Case Presentation in Advanced Colon Cancer
Case Presentation in Advanced Colon Cancer Case: 1
Considerations Following Locoregional Therapy in HCC
Initial Strategies in Advanced HCC: Case 2
Initial Strategies in Advanced HCC
Initial Strategies in Advanced HCC: Case 1
Management of Platinum-Resistant Ovarian Cancer
Treatment of EGFR Mutant Non-Small Cell Lung Cancer
NSCLC with Multiple Sites of Metastasis and No Driver Mutation
Metastatic Lung Adenocarcinoma Without a Driver Mutation
Underlying Treatment of Myeloproliferative Neoplasms
The Therapeutic Approach for Malignant Melanoma: Case 2
The Therapeutic Approach for Malignant Melanoma
The Therapeutic Approach for Malignant Melanoma: Case 1
Chemotherapy for Metastatic Pancreatic Cancer
Long-Term Strategies in Advanced HCC
Later Line Therapeutic Decisions in Metastatic HCC: Case 2
Later Line Therapeutic Decisions in Metastatic HCC
Treatment of Malignant Melanoma